RootPath Announces Presentation and Fireside Chat at Built With Biology 2022

RootPath, a synthetic biology company that elevates the throughput of gene function interrogation by orders of magnitude, today announced that CEO and Co-Founder, Xi Chen, will present an overview of RootPath’s gene synthesis platform PathFinder DNA Assembly™ and Nano Toothpick™ at the Built With Biology Conference on April 13, 2022 at 12:30 pm PDT in Oakland, California.

Susana Donkor, a research associate at RootPath, will participate in a fireside chat at the Built With Biology Conference on April 12, 2022 at 5:25 PM PDT.

About RootPath

RootPath is a synthetic biology company that elevates the throughput of gene function interrogation by orders of magnitude. Our Molecular Programming-based DNA fragment assembly technology gives researchers and drug developers unprecedented, equitable access to long synthetic genes and their functional readouts. By applying our technology to mine a patient’s immunome, we create truly personalized T cell therapies for solid tumors. Together, with leading partners, we are exploring new applications across multiple industries. We enable biology at scale.

Contacts

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  210.11
+5.25 (2.56%)
AAPL  264.58
+4.00 (1.54%)
AMD  200.15
-3.22 (-1.58%)
BAC  53.06
+0.29 (0.55%)
GOOG  314.90
+11.34 (3.74%)
META  655.66
+10.88 (1.69%)
MSFT  397.23
-1.23 (-0.31%)
NVDA  189.82
+1.92 (1.02%)
ORCL  148.08
-8.46 (-5.40%)
TSLA  411.82
+0.11 (0.03%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.